The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Reflecting growing optimism in the sports nutrition sector, Deutsche Bank has raised its price target for Applied Nutrition from 306p to 335p while maintaining a 'buy' rating. This upward revision follows strong trading performance across all global regions and the successful execution of a strategic acquisition in the US market. Furthermore, management has issued revised guidance expecting revenues to reach approximately £148 million for FY2026, representing a robust growth rate of 38%.
This bullish outlook comes as the sector sees varying performance among peers; for instance, Glanbia recently reported a more modest revenue growth of 4.1% per market data, positioning Applied Nutrition's 38% target as a significant outperformance of industry averages. Analysts note that the US expansion is the primary catalyst for this valuation hike, as the company aggressively targets market share in the world's largest nutritional supplement market.
Sign in to access this content
Sign InInvestors are currently monitoring the stock's price action to see if it converges toward the new 335p target. Looking ahead, market participants should watch for upcoming inflation data (CPI) releases in major economies, as noted in the economic calendar, which could influence consumer spending sentiment and broader risk appetite for growth-oriented consumer stocks.